medigraphic.com
ISSN 0016-3813 (Print)

2013, Number 6

<< Back Next >>

Gac Med Mex 2013; 149 (6)

Primary hyperaldosteronism by unilateral adrenal hyperplasia: a report of two cases

Ferreira-Hermosillo A, Hernández-Martínez ÁF, Hernández-García I, Molina-Ayala M

Language: Spanish
References: 23
Page: 668-672
PDF size: 250.72 Kb.


ABSTRACT

Primary aldosteronism (PA) is actually the main cause of adrenal-endocrine hypertension. This syndrome is characterized by hypertension, hypokalemia, suppressed plasma renin activity, and increased aldosterone excretion. The most common causes of this syndrome are bilateral idiopathic hyperaldosteronism and aldosterone producing adenoma (Conn’s syndrome) and less frequently unilateral adrenal hyperplasia, adrenal carcinoma, or familial hyperaldosteronism. Unilateral adrenal hyperplasia (UAP) constitutes 2% of the causes of PA. We present the case of two patients with UAP. (Gac Med Mex. 2013;149:668-72)


REFERENCES

  1. Young WF Jr. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology. 2003;144(6):2208-13.

  2. Mattsson C, Young WF Jr. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol. 2006;2(4):198-208; quiz, 191 p following 230.

  3. Amar L, Plouin PF, Steichen O. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis. 2010;5:9.

  4. Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD. Laboratory investigation of primary aldosteronism. Clin Biochem Rev. 2010;31(2):39-56.

  5. Enberg U, Volpe C, Hoog A, et al. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol. 2004;151(1):73-85.

  6. Ferreira-Hermosillo A, Bernal-Garduño J, Hernández-García I, Molina- Ayala M. Debilidad muscular en un paciente con hipertensión arterial sistémica. Revista de Endocrinología y Nutrición. 2010;18(4):194-6.

  7. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266-81.

  8. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007;66(5):607-18.

  9. Cortes P, Fardella C, Oestreicher E, et al. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach]. Rev Med Chil. 2000;128(9):955-61.

  10. Fardella CE, Mosso L, Gomez-Sanchez C, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85(5):1863-7.

  11. Tiu SC, Choi CH, Shek CC, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab. 2005;90(1):72-8.

  12. Rossi GP, Ganzaroli C, Miotto D, et al. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens. 2006;24(2):371-9.

  13. Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005;25 Suppl 1:S143-58.

  14. Kotsaftis P, Savopoulos C, Agapakis D, et al. Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report. Cases J. 2009;2:6813.

  15. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193-202.

  16. Chen SY, Shen SJ, Chou CW, Yang CY, Cheng HM. Primary aldosteronism caused by unilateral adrenal hyperplasia: rethinking the accuracy of imaging studies. J Chin Med Assoc. 2006;69(3):125-9.

  17. Katayama Y, Takata N, Tamura T, et al. A case of primary aldosteronism due to unilateral adrenal hyperplasia. Hypertens Res. 2005;28(4):379-84.

  18. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163-9.

  19. Karagiannis A, Tziomalos K, Kakafika A, Harsoulis F, Zamboulis C. Paralysis as first manifestation of primary aldosteronism. Nephrol Dial Transplant. 2004;19(9):2418-9.

  20. Huang YY, Hsu BR, Tsai JS. Paralytic myopathy--a leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab. 1996;81(11):4038-41.

  21. Goh BK, Tan YH, Chang KT, Eng PH, Yip SK, Cheng CW. Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases. World J Surg. 2007;31(1):72-9.

  22. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136(6):1227-35.

  23. Doppman JL, Gill JR Jr. Hyperaldosteronism: sampling the adrenal veins. Radiology. 1996;198(2):309-12.




2020     |     www.medigraphic.com